glp-1 chronic fatigue syndrome Side Effects: When to Call a Doctor If you're on a GLP-1

The efficacy and safety of the new GLP-1 medicines continues to garner interest and will be discussed #ADA2024 Here is an updated safety-focused summary of the field and where it might be headed @DiabetesCareADA #T2D #obesity pic.twitter.com/rtEQYtHQG0 Daniel J Drucker (@DanielJDrucker) June 6, 2024 Investigational GLP-1 medicines in the clinic Late-stage investigational GLP-1 medicines for type 2 diabetes and obesity include new molecules like retatrutide and orforglipron, showing potential differentiation from semaglutide and tirzepatide through better tolerability, greater weight loss, Hb A 1c reduction, and targeted outcomes

PlexusDx assessment protocols evaluate each patient's complete metabolic profile rather than using BMI as an absolute gatekeeper

The answer was cautious

It slows digestion and reduces appetite, helping patients lose significant body weight when combined with lifestyle changes

Note that these medications are not insulin and are not suitable for type 1 diabetes

Please watch the video below to learn how to safely self-inject your GLP-1 medication as prescribed